Shockwave Medical Inc has secured an additional $35m in a series C venture financing round led by Fidelity Management and Research Company.

The US-based company had previously secured $45m last November, while the latest round has increased the total funding to $80m.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company plans to use the funds to develop its Peripheral and Coronary Lithoplasty Systems in the US and Europe.

Theraclion SA has signed an agreement with EDAP TMS SA to distribute its Echopulse system in France.

Both companies involved in the transaction are based in France.

“The US-based ophthalmic company plans to use the funds towards establishing a marketing team and to launch new products.”

New Zealand-based cancer diagnostics company Pacific Edge Ltd has announced a rights offering of 66 million shares priced at $0.32 a share to raise $21.3m.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Avita Medical Ltd has announced the rights offering of 276.5 million shares priced at A$0.05 ($0.3) each to raise A$12.44m ($9.65m). The company previously announced the private placement of 101 million shares priced at A$0.05 ($0.3) a share to raise A$4.5m ($3.49m).

The US-based medical device company plans to use the funds towards working capital purposes.

Sight Sciences Inc has secured $10m in a series C financing round led by Allegro Investment Fund.

The US-based ophthalmic company plans to use the funds towards establishing a marketing team and to launch new products.